AXERT 12.5mg time vs Intensity Migraine Study (AIMS): an open-label multicenter trial to evaluate the efficacy of almotriptan malate (AXERT12.5 milligram intervention at onset of migraine pain.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 04 May 2010

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

05 May 2009 Actual patient number (1450) added as reported by ClinicalTrials.gov.
19 Oct 2007 Status changed from in progress to completed.
20 Nov 2005 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com